Search for: All records

Human papillomavirus (HPV) is a globally prevalent sexually-transmitted pathogen, responsible for most cases of cervical cancer. HPV vaccination rates remain suboptimal, partly due to the need for multiple doses, leading to a lack of compliance and incomplete protection. To address the drawbacks of current HPV vaccines, we used a scalable manufacturing process to prepare implantable polymer–protein blends for single-administration with sustained delivery. Peptide epitopes from HPV16 capsid protein L2 were conjugated to the virus-like particles derived from bacteriophage Qβ, to enhance their immunogenicity. The HPV-Qβ particles were then encapsulated into poly(lactic-co-glycolic acid) (PLGA) implants, using a benchtop melt-processing system. The implants facilitated the slow and sustained release of HPV-Qβ particles without the loss of nanoparticle integrity, during high temperature melt processing. Mice vaccinated with the implants generated IgG titers comparable to the traditional soluble injections and achieved protection in a pseudovirus neutralization assay. HPV-Qβ implants offer a new vaccination platform; because the melt-processing is so versatile, the technology offers the opportunity for massive upscale into any geometric form factor. Notably, microneedle patches would allow for self-administration in the absence of a healthcare professional, within the developing world. The Qβ technology is highly adaptable, allowing the production of vaccine candidates and their delivery devices for multiple strains or types of viruses. 

We studied the production of levoglucosenone (LGO) via levoglucosan (LGA) dehydration using Brønsted solid acid catalysts in tetrahydrofuran (THF). The use of propylsulfonic acid functionalized silica catalysts increased the production of LGO by a factor of two compared to the use of homogeneous acid catalysts. We obtained LGO selectivities of up to 59% at 100% LGA conversion using solid Brønsted acid catalysts. Water produced during the reaction promotes the solvation of the acid proton reducing the activity and the LGO production. Using solid acid catalysts functionalized with propylsulfonic acid reduces this effect. The hydrophilicity of the catalyst surface seems to have an effect on reducing the interaction of water with the acid site, improving the catalyst stability.